Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) EPS (Weighted Average and Diluted) (2021 - 2025)

Alignment Healthcare (ALHC) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with $0.02 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 114.29% year-over-year to $0.02, compared with a TTM value of -$0.11 through Sep 2025, up 85.71%, and an annual FY2024 reading of -$0.67, up 15.19% over the prior year.
  • EPS (Weighted Average and Diluted) was $0.02 for Q3 2025 at Alignment Healthcare, down from $0.07 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.07 in Q2 2025 and bottomed at -$0.32 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.16, with a median of -$0.18 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 150.0% in 2023, then soared 153.85% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.27 in 2021, then dropped by 18.52% to -$0.32 in 2022, then rose by 21.88% to -$0.25 in 2023, then soared by 40.0% to -$0.15 in 2024, then soared by 113.33% to $0.02 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for ALHC at $0.02 in Q3 2025, $0.07 in Q2 2025, and -$0.05 in Q1 2025.